The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.

To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.

For additional information please review our Privacy Policy.


Advances in Treatment Options for Metastatic Breast Cancer: New Horizons for Cytotoxic and Targeted Agents


This presentation was selected by the American Society of Clinical Oncology® as an independent educational activity held in conjunction with an ASCO meeting. This presentation is not sponsored or endorsed by ASCO.

Advances in Treatment Options for Metastatic Breast Cancer: New Horizons for Cytotoxic and Targeted Agents

Welcome and Introductions
Speaker: William J. Gradishar

Towards Personalized Therapies in Metastatic Breast Cancers
Speaker: Branimir I. Sikic

The Epothilones: Circumventing Resistance to a Familiar Target
Speaker: Hope Rugo

Case Discussions: Chemotherapeutic Options for Matastatic Breast Cancer
Speaker: William J. Gradishar

The Future of Cytotoxics in the Age of Targeted Therapy: Rational Combination Regimens
Speaker: David Miles





 
2318 Mill Road, Suite 800, Alexandria, VA 22314   |   phone: (571) 483-1300
© 2005-2009 American Society of Clinical Oncology (ASCO).  All rights reserved worldwide.